Summary
The authors have studied different brain tumours with immunohistochemical technique using fluorescence and peroxidase methods. On frozen sections reactions for fibronectin (FN), prostaglandin E 2 (PGE 2), carcinoembryonic antigen (CEA) with polyclonal antibodies and for lymphocyte subpopulations B, NK and Pan-T with monoclonal antibodies have been investigated.
Both primary and metastatic tumours contained fibronectin in various intensity and showed increased reactions with PGE 2 antibodies comparing with surrounding tissues. A well developed FN positive fibrillary network in tumour tissue confirmed the presence of angiogenesis and visualised abnormalities of the vessel walls with focal disruptions.
The intracytoplasmatic location of PGE 2, more intense than in surrounding tissues revealed in this study, may indicate that tumour cells are capable of its production. Since prostaglandin inhibits lymphocyte cytotoxicity against tumour cells in vitro, this may be suggestive for its activity in tumour defence reaction.
CEA was not found in primary brain tumours by immunohistochemical procedure, either fluorescence or peroxidase method. It has been detected only in metastatic carcinomatous tumours in moderate intensity.
Immunostaining for subpopulations of lymphocytes in tumour slices with monoclonal antibodies showed only small number of cells in some specimens. The reasons for this failure are discussed.
The meaning of all these findings mentioned above for clinical purposes is considered. The application of immunohistochemical staining may be useful in diagnosing tumour of vague or doubtful microscopic appearances.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Attalah A, Lee JB, Ambrus JL, Ambrus CM, Karakousis C, Takita H (1984) Prostaglandin E2 production by human tumours. Defense mechanism against the host? A preliminary report. Res Corn Chem Path Pharm 43: 195–201
Bevilaqua M, Mosesson MW, Bianco C (1980) Fibronectin receptors on mononuclear phagocytes. Clin Res 28: 340A - 340A
Breborowicz D, Gladysz K, Slowik-Gabryelska A, Zengteler G, Breborowicz J (1985) Carcinoembryonic antigen in lung cancer — II Immunohistochemical study (Polish). Immun Pol 10: 345–354
Brooks WH, Netsky MG, Levine JE (1975) Immunity and tumours of the nervous system. Surg Neurol 3: 184–186
Fukushima M, Kato T, Ueda R, Ota K, Narumiya S, Hayashi O (1982) Prostaglandin D 2 a potential antineoplastic agent. Biochem Biophys Res Commun 105: 956–965
Humes TL, Strausser HR (1974) Prostaglandins and cyclic nucleotides in Moloney sarcoma tumours. Prostaglandins 5: 183–196
Imielinski BL (1980) Intracranial tumours of childhood. Etiopathogenic, diagnostic and therapeutic considerations; perspectives of non-conventional treatment. Garyounis MJ 3: 187–198
Miyake A, Yamashita M, Kitamura K, Ishigami F (1979) Carcinoembryonic antigen ( CEA) levels in patients with brain tumours. Acta Neurochir (Wien) 46: 53–57
Mosesson MW, Amrani DL (1980) The structure and biologic activities of plasma fibronectin. Blood 56: 145–158
Pearlstein E, Gold LJ, Garcia-Pardo A (1980) Fibronectin: a review of its structure and biological activity. Mol Cell Biochem 29: 103–128
Robertson RP, Baylink DJ, Metz SA, Cumonings KB (1976) Plasma prostaglandin E in patients with cancer with and without hypercalcaemia. J Clin Endocrinol Metab 43: 1330–1335
Sakai T, Yamaguchi N (1984) Prostaglandin D 2 inhibits the proliferation of human malignant tumour cells. Prostaglandins 27: 17–27
Schnegg JF, Diserens AC, Carrel S, Accola RS, De Tribolet N (1981) Human glioma associated antigens detected by monoclonal antibodies. Cancer Res 41: 1209–1213
Seyberth HW, Segre GV, Morgan JL, Sweetman BJ, Potts JT Jr, Oates JA (1975) Prostaglandins as mediators of hypercalcaemia associated with certain types of cancer. N Engl J Med 293: 1278–1283
Simmet T, Jaffe BM (1983) Inhibition of B 16 melanoma growth in vitro by prostaglandin D 2. Prostaglandins 25: 47–54
Taylor CR, Burnes J (1974) The demonstration of plasma cells and other immunoglobulin containing cells in formalin fixed paraffin embedded tissues using peroxidase-labelled antibody. J Clin Path 27: 14–20
Vaheri A, Ruoslahti E, Westermark B, Ponten J (1976) A common cell-type specific surface antigen in cultured human glial cells and fibroblasts: loss in malignant cells. J Exp Med 143: 64–72
Westphal M, Neuss M, Herrmann HD (1986) Prostaglandins: anti-proliferative effect of PGD 2 on cultured human glioma. Acta Neurochir (Wien) 83: 56–61
Wilson C, Normansell DE, Netsky MG (1974) Antigenicity of foetal and adult cerebral tissue of man. Neurology 24: 761–766
Zóltowska A (1987) Human tumours and prostaglandin E 2 (in press)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag
About this paper
Cite this paper
Imieliński, B.L., Borowska-Lehman, J., Żółtowska, A. (1988). Immunological and Immunohistochemical Studies in Brain Tumours. In: Isamat, F., Jefferson, A., Loew, F., Symon, L. (eds) Proceedings of the 8th European Congress of Neurosurgery, Barcelona, September 6–11, 1987. Acta Neurochirurgica, vol 43. Springer, Vienna. https://doi.org/10.1007/978-3-7091-8978-8_29
Download citation
DOI: https://doi.org/10.1007/978-3-7091-8978-8_29
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-8980-1
Online ISBN: 978-3-7091-8978-8
eBook Packages: Springer Book Archive